These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 7717094

  • 1. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
    Priest RG, Gimbrett R, Roberts M, Steinert J.
    Acta Psychiatr Scand Suppl; 1995; 386():40-3. PubMed ID: 7717094
    [Abstract] [Full Text] [Related]

  • 2. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders.
    Liebowitz MR, Hollander E, Schneier F, Campeas R, Welkowitz L, Hatterer J, Fallon B.
    Acta Psychiatr Scand Suppl; 1990; 360():29-34. PubMed ID: 2248064
    [Abstract] [Full Text] [Related]

  • 3. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
    Roth M, Guelfi JD.
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
    [Abstract] [Full Text] [Related]

  • 4. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression.
    Lotufo-Neto F, Trivedi M, Thase ME.
    Neuropsychopharmacology; 1999 Mar; 20(3):226-47. PubMed ID: 10063483
    [Abstract] [Full Text] [Related]

  • 5. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
    Stabl M, Biziére K, Schmid-Burgk W, Amrein R.
    J Neural Transm Suppl; 1989 Mar; 28():77-89. PubMed ID: 2677244
    [Abstract] [Full Text] [Related]

  • 6. Moclobemide: therapeutic use and clinical studies.
    Bonnet U.
    CNS Drug Rev; 2003 Mar; 9(1):97-140. PubMed ID: 12595913
    [Abstract] [Full Text] [Related]

  • 7. Medication treatments for panic disorder and social phobia.
    Stein MB.
    Depress Anxiety; 1998 Mar; 7(3):134-8. PubMed ID: 9656095
    [Abstract] [Full Text] [Related]

  • 8. Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients.
    Nair NP, Ahmed SK, Kin NM, West TE.
    Acta Psychiatr Scand Suppl; 1995 Mar; 386():28-35. PubMed ID: 7717092
    [Abstract] [Full Text] [Related]

  • 9. Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorder.
    Laux G, Classen W, Sofic E, Becker T, Riederer P, Lesch KP, Struck M, Beckmann H.
    J Neural Transm Suppl; 1990 Mar; 32():189-95. PubMed ID: 2089089
    [Abstract] [Full Text] [Related]

  • 10. RIMA--a new concept in the treatment of depression with moclobemide.
    Amrein R, Hetzel W, Stabl M, Schmid-Burgk W.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
    [Abstract] [Full Text] [Related]

  • 11. Moclobemide in the treatment of social phobia.
    Nutt D, Montgomery SA.
    Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():77-82. PubMed ID: 8923114
    [Abstract] [Full Text] [Related]

  • 12. Moclobemide. An update of its pharmacological properties and therapeutic use.
    Fulton B, Benfield P.
    Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
    Delini-Stula A, Mikkelsen H, Angst J.
    J Affect Disord; 1995 Oct 09; 35(1-2):21-30. PubMed ID: 8557884
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of the reversible monoamine oxidase-A inhibitor brofaromine in social phobia complicated by panic disorder with or without agoraphobia.
    Bakish D.
    J Clin Psychopharmacol; 1994 Feb 09; 14(1):74-5. PubMed ID: 8151007
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice].
    Da Prada M, Keller HH, Kettler R.
    Psychiatr Prax; 1989 Aug 09; 16 Suppl 1():18-24. PubMed ID: 2587673
    [Abstract] [Full Text] [Related]

  • 19. Moclobemide--placebo-controlled trials.
    Silverstone T.
    Int Clin Psychopharmacol; 1993 Jan 09; 7(3-4):133-6. PubMed ID: 8468433
    [Abstract] [Full Text] [Related]

  • 20. Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder.
    Tiller JW, Bouwer C, Behnke K.
    Int Clin Psychopharmacol; 1997 Oct 09; 12 Suppl 6():S27-30. PubMed ID: 9466172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.